MoneyWorks4Me

Guj. Themis Biosyn - Quaterly Results

08 Aug 2026 Evaluate
The Revenue for the quarter ended  June 2026 of Rs. 437.90 millions grew by 22.07 % from Rs. 358.73 millions.Modest increase of 22.13% in the Net Profit was reported from. 90.62 millions to Rs. 110.67  millions.Operating profit for the quarter ended June 2026 rose to 209.26 millions as compared to 141.96 millions of corresponding quarter ended June 2025.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 437.90 358.73 22.07 437.90 358.73 22.07 1658.23 1508.00 9.96
Other Income 1.32 2.74 -51.82 1.32 2.74 -51.82 24.28 24.32 -0.16
PBIDT 209.26 141.96 47.41 209.26 141.96 47.41 779.58 712.76 9.37
Interest 17.87 0.42 4154.76 17.87 0.42 4154.76 29.49 3.64 710.16
PBDT 191.39 141.54 35.22 191.39 141.54 35.22 750.09 709.12 5.78
Depreciation 39.73 20.34 95.33 39.73 20.34 95.33 129.19 53.75 140.35
PBT 151.66 121.20 25.13 151.66 121.20 25.13 620.90 655.37 -5.26
TAX 40.99 30.58 34.04 40.99 30.58 34.04 154.08 167.66 -8.10
Deferred Tax 13.82 5.92 133.45 13.82 5.92 133.45 46.22 2.80 1550.71
PAT 110.67 90.62 22.13 110.67 90.62 22.13 466.82 487.71 -4.28
Equity 108.97 108.97 0.00 108.97 108.97 0.00 108.97 108.97 0.00
PBIDTM(%) 47.79 39.57 20.76 47.79 39.57 20.76 47.01 47.27 -0.53
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..